APA (7th ed.) Citation

YL, N., Y, Y., JF, S., MF, H., & DM, W. (2026). Case Report: Furmonertinib-induced acute interstitial lung disease. Frontiers in pharmacology, 16, 1742670. https://doi.org/10.3389/fphar.2025.1742670

Chicago Style (17th ed.) Citation

YL, Niu, Yang Y, Shi JF, Han MF, and Wang DM. "Case Report: Furmonertinib-induced Acute Interstitial Lung Disease." Frontiers in Pharmacology 16 (2026): 1742670. https://doi.org/10.3389/fphar.2025.1742670.

MLA (9th ed.) Citation

YL, Niu, et al. "Case Report: Furmonertinib-induced Acute Interstitial Lung Disease." Frontiers in Pharmacology, vol. 16, 2026, p. 1742670, https://doi.org/10.3389/fphar.2025.1742670.